Information Holdings Inc.

Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on:

Monday, December 4, 2023

Biotechnology, Pharmaceutical, Health, COVID-19, Infectious Diseases, Health Technology, Genetics, Clinical Trials, Webcast, Liver, ARCT, Infection, Information Holdings Inc., Conference, Vaccine, RNA, Pharmaceutical industry, Cryptocurrency

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, on Tuesday, January 9, 2024, at 3:00 p.m. Pacific Time.

Key Points:

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, on Tuesday, January 9, 2024, at 3:00 p.m. Pacific Time.
A webcast and replay of the presentation will be available on the “Investor Relations/Events” section of the Company’s website at: https://ir.arcturusrx.com/investor-calendar .

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis

Retrieved on:

Monday, November 27, 2023

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for the Company’s product candidate ARCT-032 to treat cystic fibrosis (CF).

Key Points:

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for the Company’s product candidate ARCT-032 to treat cystic fibrosis (CF).
The FDA’s Office of Orphan Products Development grants orphan status to drugs being developed to treat, prevent, or diagnose a rare disease or condition affecting fewer than 200,000 people in the United States.
“Orphan Drug Designation is a very important regulatory milestone in our development plan for ARCT-032,” said Joseph Payne, President, and Chief Executive Officer of Arcturus Therapeutics.
"We are executing diligently to accelerate ARCT-032 as a potential new treatment option for people with cystic fibrosis.”
The first CF patient in our Phase 1b study successfully completed two administrations of ARCT-032.

IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023

Retrieved on:

Tuesday, November 21, 2023

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on Wednesday, November 29, 2023 at 10:50 a.m.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on Wednesday, November 29, 2023 at 10:50 a.m.
ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com .
A replay of the webcast will be available later that day.

36Kr Holdings Inc. Reports Third Quarter 2023 Unaudited Financial Results

Retrieved on:

Thursday, December 7, 2023

Online, Research, Investment, Information Holdings Inc., ADS, Marketing, Growth, AI, New economy, Video game, Music, Beauty salon, Pharmaceutical industry

Mr. Dagang Feng, Co-chairman and CEO of 36Kr, commented, "We delivered another quarter of solid top-line growth in the third quarter of 2023 despite uncertainties in the macro environment.

Key Points:

Mr. Dagang Feng, Co-chairman and CEO of 36Kr, commented, "We delivered another quarter of solid top-line growth in the third quarter of 2023 despite uncertainties in the macro environment.
Ms. Lin Wei, Chief Financial Officer of 36Kr, added, "We maintained our growth trajectory in the third quarter of 2023.
Gross profit margin was 56.3% in the third quarter of 2023, compared to 62.4% in the same period of 2022.
Net loss attributable to 36Kr Holdings Inc.'s ordinary shareholders was RMB18.9 million (US$2.6 million) in the third quarter of 2023, compared to net income attributable to 36Kr Holdings Inc.'s ordinary shareholders of RMB1.7 million in the same period of 2022.

Greenidge Generation Reports Third Quarter 2023

Retrieved on:

Tuesday, November 14, 2023

Growth, Miner, Information Holdings Inc., GAAP, Adjustment, Cryptocurrency, Rare-earth element, Video game, Greenidge

FAIRFIELD, Conn., Nov. 14, 2023 /PRNewswire/ -- Greenidge Generation Holdings Inc. (NASDAQ: GREE) ("Greenidge" or the "Company"), a vertically integrated cryptocurrency datacenter and power generation company, today announced financial and operating results for the third quarter of 2023.

Key Points:

FAIRFIELD, Conn., Nov. 14, 2023 /PRNewswire/ -- Greenidge Generation Holdings Inc. (NASDAQ: GREE) ("Greenidge" or the "Company"), a vertically integrated cryptocurrency datacenter and power generation company, today announced financial and operating results for the third quarter of 2023.
"Our results for the third quarter of 2023 reflect our shift to a stable revenue mix among hosting, self-mining, and energy," said Dave Anderson, Chief Executive Officer of Greenidge.
Greenidge broke even on Adjusted EBITDA for the third quarter compared to the prior year third quarter Adjusted EBITDA loss of $3.7 million.
As of September 30, 2023, Greenidge had cash of $10.7 million and debt balance of $94.0 million, which was reduced from $157.5 million as of December 31, 2022.

Luminosity Gaming Returns to Rocket League

Retrieved on:

Friday, November 3, 2023

Enthusiasm, Rocket League, EGLX, Organization, OpTic Gaming, Luminosity, Violence, Luminosity Gaming, Blood, Gun, TSX, Information Holdings Inc., Video game, Sport

LOS ANGELES, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX) today announced that Luminosity Gaming , the Company’s esports brand and one of the largest esports organizations in the world, has returned to Rocket League after a one-year hiatus.

Key Points:

LOS ANGELES, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX) today announced that Luminosity Gaming , the Company’s esports brand and one of the largest esports organizations in the world, has returned to Rocket League after a one-year hiatus.
In connection with its return, Luminosity Gaming has secured two of the top North American competitors and former OpTic Gaming team members Retals and MaJicBear , positioning Luminosity to be immediately competitive in the North American scene.
“We have been waiting on the sidelines to find the right team to return to Rocket League, and we couldn’t be more excited that two of the most sought after talents of the off-season, Retals and MaJicBear, have decided to join Luminosity,” commented Alex Gonzalez, Head of Luminosity Gaming.
“Brands need gaming strategies to engage young audiences,” added Nick Brien, Chief Executive Officer of Enthusiast Gaming “The return of a Luminosity Gaming Rocket League team adds another engaged community to our vast portfolio of gaming assets.

IQVIA Reports Third-Quarter 2023 Results

Retrieved on:

Wednesday, November 1, 2023

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2023.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2023.
As of September 30, 2023, R&DS contracted backlog, including reimbursed expenses, was $28.8 billion, growing 11.7 percent year-over-year and 10.5 percent at constant currency.
IQVIA had $2,592 million of share repurchase authorization remaining as of September 30, 2023.
IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its third-quarter 2023 results and its fourth-quarter and full-year 2023 guidance.

First-of-its-kind Sleep Country and Silk & Snow collaborative store opens in Ottawa's Westboro neighbourhood

Retrieved on:

Friday, October 27, 2023

Sleep Country Canada, Country, Ceramic, Growth, Wood, Architecture, Silk, System, Entrepreneurship, TSX, Benoy, Information Holdings Inc., Sleep, Hotel

OTTAWA, ON, Oct. 27, 2023 /CNW/ - Sleep Country Canada Holdings Inc. ("Sleep Country" or the "Company") (TSX: ZZZ), Canada's leading specialty sleep retailer, is pleased to announce plans to awaken more Canadians to the power of sleep with a new Ottawa store in collaboration with its premium sleep and lifestyle banner brand, Silk & Snow.

Key Points:

OTTAWA, ON, Oct. 27, 2023 /CNW/ - Sleep Country Canada Holdings Inc. ("Sleep Country" or the "Company") (TSX: ZZZ), Canada's leading specialty sleep retailer, is pleased to announce plans to awaken more Canadians to the power of sleep with a new Ottawa store in collaboration with its premium sleep and lifestyle banner brand, Silk & Snow.
With the Silk & Snow portion of the collaborative store set to open in late November, the new location is a conceptual first for Sleep Country with a large physical footprint dedicated to one of its newest direct-to-consumer brands.
"We're very excited to bring Silk & Snow, a leading, direct-to-consumer brand, into its very first tactile environment," said Stewart Schaefer, President and Chief Executive Officer, Sleep Country.
The new store is the first retail location for Silk & Snow, the fast-growing brand of high-quality sleep and lifestyle products, including mattresses, bedding, furniture, sleep accessories and bath essentials.

Herc Holdings Inc. Announces Investor Day to be Held on November 2, 2023

Retrieved on:

Tuesday, October 17, 2023

Fleet Management, Automotive, Machinery, Other Transport, Trucking, Other Automotive, Transport, Manufacturing, Senior, HRI, NYSE, Information Holdings Inc., Management

Herc Holdings Inc. (NYSE: HRI), one of North America’s leading equipment rental suppliers, will host an Investor Day at its Bonita Springs, FL., headquarters on Thursday, November 2, 2023, from 9:00 a.m. to 11:00 a.m. Eastern Time.

Key Points:

Herc Holdings Inc. (NYSE: HRI), one of North America’s leading equipment rental suppliers, will host an Investor Day at its Bonita Springs, FL., headquarters on Thursday, November 2, 2023, from 9:00 a.m. to 11:00 a.m. Eastern Time.
Senior management, including Larry Silber, president and chief executive officer; Aaron Birnbaum, senior vice president and chief operating officer; and Mark Humphrey, senior vice president and chief financial officer, will provide a progress update on its long-term strategies and capital allocation priorities, and will introduce new, three-year performance targets.
The live webcast will be available on the Events and Presentations page of the company’s investor relations website at: https://ir.hercrentals.com/events-and-presentations/11-02-2023

Knight-Swift Transportation Holdings Inc. Announces Participation in Upcoming Conferences

Retrieved on:

Thursday, October 12, 2023

Trucking, Transport, Logistics, Supply Chain Management, Senior, KNX, NYSE, Information Holdings Inc., Conference, Management, Swift

Knight-Swift Transportation Holdings Inc. (NYSE: KNX) announced today that David Jackson, President and Chief Executive Officer, Adam Miller, Chief Financial Officer and President of Swift, and Brad Stewart, Treasurer and Senior Vice President of Investor Relations, are scheduled to participate in the following upcoming transportation conferences:

Key Points:

Knight-Swift Transportation Holdings Inc. (NYSE: KNX) announced today that David Jackson, President and Chief Executive Officer, Adam Miller, Chief Financial Officer and President of Swift, and Brad Stewart, Treasurer and Senior Vice President of Investor Relations, are scheduled to participate in the following upcoming transportation conferences:
Baird Global Industrial Conference – Thursday, November 9, 2023
Stephens Annual Investment Conference – Wednesday, November 15, 2023